Abstract
We introduce a lightweight model based on Mask R-CNN with ResNet18 and ResNet34 backbone models that segments lesions and predicts COVID-19 from chest CT scans in a single shot. The model requires a small dataset to train: 650 images for the segmentation branch and 3000 for the classification branch, and it is evaluated on 21292 images to achieve a 42.45% average precision (main MS COCO criterion) on the segmentation test split (100 images), 93.00% COVID-19 sensitivity and F1-score of 96.76% on the classification test split (21192 images) across 3 classes: COVID-19, Common Pneumonia and Control/Negative. The full source code, models and pretrained weights are available on https://github.com/AlexTS1980/COVID-Single-Shot-Model.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
N/A
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.